Nutritional supplements, namely, probiotic compositions; Anti-arthritic compositions and preparations; Medicaments for inhibiting the growth and metastasis of malignant cells; Medicaments for enhancing resposiveness of malignant cells to chemotherapeutic agents; Medicaments for targeting cancer linked cellular pathways and targeting mTOR, STAT3, and NF-kB and Notch pathways; Medicaments for enhancing apoptosis in cells subjected to glucose deprivation; Medicaments for enhancing ROS-activated and JNK-mediated apoptosis in cells subjected to glucose deprivation
Live/Registered
on 09 Apr 2024
NICLOMED
Right2Try
97319416 · 18 Mar 2022
09 Apr 2030
005
Class 005
Pharmaceutical Products
Nutritional supplements, namely, probiotic compositions; Anti-arthritic compositions and preparations; Medicaments for inhibiting the growth and metastasis of malignant cells; Medicaments for enhancing resposiveness of malignant cells to chemotherapeutic agents; Medicaments for targeting cancer linked cellular pathways and targeting mTOR, STAT3, and NF-kB and Notch pathways; Medicaments for enhancing apoptosis in cells subjected to glucose deprivation; Medicaments for enhancing ROS-activated and JNK-mediated apoptosis in cells subjected to glucose deprivation